Table 3.
Unadjusted outcomes
| Outcome (cohort) | Cohort N | N a | n (%) | Baseline, mean (SD) | Follow‐up, mean (SD) | Difference, mean (SD) | P value |
|---|---|---|---|---|---|---|---|
| Weight at 6‐months (≥ 6‐month), kg | 167 | 145 | N/A | 117.6 (31.0) | 109.6 (31.0) | −8.00 (6.12) | <0.001 |
| Weight at 6 months (All Subjects), kg | 311 | 203 | N/A | 115.5 (28.4) | 108.2 (28.2) | −7.28 (6.20) | <0.001 |
| Weight at 4 months (≥ 4‐month), kg | 210 | 187 | N/A | 115.9 (28.8) | 108.9 (28.5) | −7.00 (4.53) | <0.001 |
| % Weight loss at 6 mo (≥ 6‐month), % | 167 | 145 | N/A | N/A | N/A | −7.1 (5.4) | N/A |
| % Weight loss at 6 mo (All Subjects), % | 311 | 203 | N/A | N/A | N/A | −6.5 (5.5) | N/A |
| % Weight loss at 4 mo (≥ 4‐month), % | 210 | 187 | N/A | N/A | N/A | −6.3 (4.1) | N/A |
| Loss of ≥ 5 % body weight at 6 mo (≥ 6‐month) | 167 | 145 | 93 (64.1) | N/A | N/A | N/A | N/A |
| Loss of ≥ 5 % body weight at 6 mo (All Subjects) | 311 | 203 | 119 (58.6) | N/A | N/A | N/A | N/A |
| Loss of ≥ 5 % body weight at 4 mo (≥ 4‐month) | 210 | 187 | 118 (63.1) | N/A | N/A | N/A | N/A |
| Loss of > 10% body weight at 6 mo (≥ 6‐month) | 167 | 145 | 50 (34.5) | N/A | N/A | N/A | N/A |
| Loss of > 10% body weight at 6 mo (All Subjects) | 311 | 203 | 60 (29.6) | N/A | N/A | N/A | N/A |
| Loss of > 10% body weight at 4 mo (≥ 4‐month) | 210 | 187 | 34 (18.2) | N/A | N/A | N/A | N/A |
| HbA1c at 6 mo (≥ 6‐month), % | 167 | 30 | N/A | 5.7 (0.5) | 5.3 (0.4) | −0.35 (0.28) | <0.001 |
| HbA1c at 6 mo (All Subjects), % | 311 | 39 | N/A | 5.6 (0.5) | 5.3 (0.4) | −0.30 (0.31) | <0.001 |
| SBP at 6 mo (≥ 6‐month), mmHg | 167 | 136 | N/A | 127.8 (10.5) | 124.8 (11.7) | −2.98 (10.67) | <0.01 |
| SBP at 6 mo (All Subjects), mmHg | 311 | 185 | N/A | 127.6 (10.6) | 125.4 (12.2) | −2.23 (11.20) | <0.01 |
| DBP at 6 mo (≥ 6‐month), mmHg | 167 | 136 | N/A | 77.5 (7.6) | 77.5 (8.4) | 0.10 (8.57) | 0.897 |
| DBP at 6 mo (All Subjects), mmHg | 311 | 187 | N/A | 77.2 (7.7) | 77.7 (8.5) | 0.51 (8.91) | 0.437 |
These are patients for whom baseline and postindex values were available, rendering them eligible for each measure.
a
N values may differ from overall cohort numbers because of a difference in the number of participants with baseline and postindex values.
DBP, diastolic blood pressure; HbA1c, glycated hemoglobin A1c; N/A, not applicable; SBP, systolic blood pressure.